Martin S Taylor, Connie Wu, Peter C Fridy, Yasmeen Senussi, Wen-Chih Cheng, John Heaps, Kei Mori, Limor Cohen, Kelly R Molloy, Brian T Chait, Michael Goggins, Irun Bhan, Joseph W Franses, Xiaoyu Yang, Mary-Ellen Taplin, Xinan Wang, David C Christiani, Bruce E Johnson, Matthew Meyerson, Ravindra Uppaluri, Ann Marie Egloff, Elyssa N Denault, Laura M Spring, Tian-Li Wang, Ie-Ming Shih, Euihye Jung, Kshitij S Arora, Lawrence R Zukerberg, Osman H Yilmaz, Gary Chi, Bryanna L Norden, Yuhui Song, Linda Nieman, Aparna R Parikh, Matthew Strickland, Tomas Mustelin, George Eng, Ömer H Yilmaz, Ursula A Matulonis, Steven J Skates, Bo R Rueda, Ronny Drapkin, Samuel J Klempner, Vikram Deshpande, David T Ting, Michael P Rout, John LaCava, David R Walt, Kathleen H Burns
Improved biomarkers are needed for early cancer detection, risk stratification, treatment selection, and monitoring treatment response. While proteins can be useful blood-based biomarkers, many have limited sensitivity or specificity for these applications. Long INterspersed Element-1 (LINE-1, L1) open reading frame 1 protein (ORF1p) is a transposable element protein overexpressed in carcinomas and high-risk precursors during carcinogenesis with negligible detectable expression in corresponding normal tissues, suggesting ORF1p could be a highly specific cancer biomarker...
January 25, 2023: bioRxiv